# Tumor Hypoxia With HX4 PET in Several Diseases

> **NCT02584400** · PHASE2 · TERMINATED · sponsor: **Maastricht Radiation Oncology** · enrollment: 1 (actual)

## Conditions studied

- Prostatic Neoplasms
- Esophageal Neoplasms
- Neoplasm Metastases, Brain
- Rectal Neoplasms
- Brain Neoplasm, Primary

## Interventions

- **DRUG:** Injection with the hypoxia tracer [18F]HX4,

## Key facts

- **NCT ID:** NCT02584400
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** patients did not want to participate
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584400, "Tumor Hypoxia With HX4 PET in Several Diseases". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02584400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*